Payments to Acquire Property, Plant, and Equipment of Inhibrx Biosciences, Inc. from 31 Dec 2023 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Inhibrx Biosciences, Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2023 to 31 Mar 2025.
  • Inhibrx Biosciences, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $21,000, a 98% decline year-over-year.
  • Inhibrx Biosciences, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $2,597,000, a 43% decline from 2023.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Inhibrx Biosciences, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $21,000 -$1,098,000 -98% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $1,119,000 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1

Inhibrx Biosciences, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,597,000 -$1,996,000 -43% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
2023 $4,593,000 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.